Skip to main content
SpringerLink
Log in

Liver transplantation for hepatocellular carcinoma

  • Topics
  • Published:
Journal of Hepato-Biliary-Pancreatic Surgery

Abstract

The role of liver transplantation (LT) in patients with hepatocellular carcinoma (HCC) has evolved over the past two decades, and transplantation has become one of the few curative treatment modalities for patients with HCC. Early results were poor, but the current restrictive selection criteria can yield excellent results. This review will discuss recent issues in the field, including (1) factors affecting the recurrence of HCC after LT; (2) the effect of downstaging HCC before LT, including transarterial catheter chemoembolization (TACE) and radiofrequency ablation (RFA); and (3) living-donor versus deceased-donor liver transplantation for HCC patients. The most important factors that have been described to affect LT survival include the tumor size, vascular invasion, and the degree of tumor differentiation. Recently, tumor markers, including alpha-fetoprotein and des-gamma carboxy prothrombin, were reported as predictors of HCC recurrence after LT. Furthermore, the experience accumulated with locoregional therapies such as TACE and RFA as bridging procedures to LT, along with the reduced waiting time under the HCC-adjusted MELD (model for endstage liver disease) system for organ allocation has led to improved outcomes. With the recent advances in adult living-donor liver transplantation (LDLT), there may be a marked change in the role of liver transplantation for hepatic malignancies, in particular for HCC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. El-Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology 2007;132:2557–2576.

    Article  PubMed  CAS  Google Scholar 

  2. Okita K. Clinical aspects of hepatocellular carcinoma in Japan. Intern Med 2006;45:229–233.

    Article  PubMed  Google Scholar 

  3. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N Engl J Med 1999;340:745–750.

    Article  PubMed  CAS  Google Scholar 

  4. Takenaka K, Yamamoto K, Taketomi A, Itasaka H, Adachi E, Shirabe K, et al. A comparison of the surgical results in patients with hepatitis B versus hepatitis C-related hepatocellular carcinoma. Hepatology 1995;22:20–24.

    PubMed  CAS  Google Scholar 

  5. Lovet JM, Schwartz M, Mazzaferro V. Resection and liver transplantation for hepatocellular carcinoma. Semin Liver Dis 2005;25:181–200.

    Article  Google Scholar 

  6. Schwartz M, Roayaie S, Konstadoulakis M. Strategies for the management of hepatocellular carcinoma. Nat Clin Pract Oncol 2007;4:424–432.

    Article  PubMed  CAS  Google Scholar 

  7. O’Grady JG, Polson RJ, Rolles K, Calne RY, Williams R. Liver transplantation for malignant disease. Results in 93 consecutive patients. Ann Surg 1988;207:373–379.

    PubMed  CAS  Google Scholar 

  8. Ringe B, Pichlmayr R, Wittekind C, Tusch G. Surgical treatment of hepatocellular carcinoma: experience with liver resection and transplantation in 198 patients. World J Surg 1991;15:270–285.

    Article  PubMed  CAS  Google Scholar 

  9. Iwatsuki S, Starzl TE, Sheahan DG, Yokoyama I, Demetris AJ, Todo S, et al. Hepatic resection versus transplantation for hepatocellular carcinoma. Ann Surg 1991;214:221–228.

    Article  PubMed  CAS  Google Scholar 

  10. Mazzaferro V, Regalia E, Doci R, Andreola R, Pulvirenti A, Bozzetti F, et al. Liver transplantation for the treatment of small hepatocellular carcinoma. N Engl J Med 1996;334:693–699.

    Article  PubMed  CAS  Google Scholar 

  11. United Network for Organ Sharing, Policy 3.6. Available at: http://www.unos.org/policiesandbylaws/policies.asp?resources= true. Accessed October 26, 2007.

  12. Wiesner RH, Freeman RB, Mulligan DC. Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy. Gastroenterology 2004;127(Suppl):S261–S267.

    Article  PubMed  Google Scholar 

  13. Todo S, Furukawa H; on behalf of the Japan Study Group on Organ Transplantation. Living donor liver transplantation for adult patients with hepatocellular caricnoma: experience in Japan. Ann Surg 2004;240:451–461.

    Article  PubMed  Google Scholar 

  14. Benckert C, Jonas S, Thelen A, Spinelli A, Schumacher G, Heise M, et al. Liver transplantation for hepatocellular carcinoma in cirrhosis: prognostic parameters. Transplant Proc 2005;37:1693–1694.

    Article  PubMed  CAS  Google Scholar 

  15. Kim YS, Lim HK, Rhim H, Lee WJ, Joh JW, Park CK, et al. Recurrence of hepatocellular carcinoma after liver transplantation: patterns and prognostic factors based on clinical and radiologic features. AJR Am J Roentgenol 2007;189:352–382.

    Article  PubMed  Google Scholar 

  16. Hemming AW, Cattral MS, Reed AI, Van Der Werf WJ, Greig PD, Howard RJ. Liver transplantation for hepatocellular carcinoma. Ann Surg 2001;233:652–659.

    Article  PubMed  CAS  Google Scholar 

  17. Bozorgzadeh A, Orloff M, Abt P, Tsoulfas G, Younan D, Kashyap R, et al. Survival outcomes in liver transplantation for hepatocellular carcinoma, comparing impact of hepatitis C versus other etiology of cirrhosis. Liver Transpl 2007;13:807–813.

    Article  PubMed  Google Scholar 

  18. Klintmalm GB. Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome. Ann Surg 1998;228:479–490.

    Article  PubMed  CAS  Google Scholar 

  19. Hwang S, Lee SG, Joh JW, Suh KS, Kim DG. Liver transplantation for adult patients with hepatocellular carcinoma in Korea: comparison between cadaveric donor and living donor liver trasnplantation. Liver Transpl 2005;11:1265–1272.

    Article  PubMed  Google Scholar 

  20. Unitt E, Marshall A, Gelson W, Rushbrook SM, Davies S, Vowler SL, et al. Tumor lymphocytic infiltrate and recurrence of hepatocellular carcinoma following liver transplantation. J Hepatol 2006;45:246–253.

    Article  PubMed  CAS  Google Scholar 

  21. Soejima Y, Taketomi A, Yoshizumi T, Uchiyama H, Aishima S, Terashi T, et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007;83:893–899.

    Article  PubMed  Google Scholar 

  22. Takada Y, Ito T, Ueda M, Sakamoto S, Haga H, Maetani Y, et al. Living donor liver transplantation for patients with HCC exceeding the Mila criteria: a proposal of expanded criteria. Dig Dis 2007;25:299–302.

    Article  PubMed  Google Scholar 

  23. Shimada M, Yonemura Y, Ijichi H, Harada N, Shiotani S, Ninomiya M, et al. Living donor liver transplantation for hepatocellular carcinoma: a special reference to a preoperative desgamma-carboxy prothrombin value. Transplant Proc 2005;37:1177–1179.

    Article  PubMed  CAS  Google Scholar 

  24. Marrero JA, Su GL, Wei W, Emick D, Conjeevaram HS, Fontana RJ, et al. Des-gamma carboxyprothrombin can differentiate hepatocellular carcinoma from nonmalignant chronic liver disease in American patients. Hepatology 2003;37:1114–1121.

    Article  PubMed  CAS  Google Scholar 

  25. Shirabe K, Itoh S, Yoshizumi T, Soejima Y, Taketomi A, Aishima S, et al. The predictors of microvascular invasion in candidates for liver transplantation with hepatocellular carcinoma-with special reference to the serum levels of des-gamma-carboxy prothrombin. J Surg Oncol 2007;95:235–240.

    Article  PubMed  CAS  Google Scholar 

  26. Koike Y, Shiratori Y, Sato S, Obi S, Teratani T, Imamura M, et al. Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients. Cancer 2001;91:561–569.

    Article  PubMed  CAS  Google Scholar 

  27. Suzuki M, Shiraha H, Fujikawa T, Takaoka N, Ueda N, Nakanishi Y, et al. Des-gamma-carboxy prothrombin is a potential autologous growth factor for hepatocellular carcinoma. J Biol Chem 2005;280:6409–6415.

    Article  PubMed  CAS  Google Scholar 

  28. Decaens T, Roudot-Thoraval F, Bresson-Hadni S, Meyer C, Gugenheim J, Durand F, et al. Impact of pretransplantation transarterial chemoembolization on survival and recurrence after liver transplantation for hepatocellular carcinoma Liver Transpl 2005;11:767–775.

    Article  PubMed  Google Scholar 

  29. Ravaioli M, Grazi GL, Ercolani G, Fiorentino M, Cescon M, Golfieri R et al. Partial necrosis on hepatocellular carcinoma nodules facilitates tumor recurrence after liver transplantation. Transplantation 2004;78:1780–1786.

    Article  PubMed  Google Scholar 

  30. Liou TC, Shih SC, Kao CR, Chou SY, Lin SC, Wang HY. Pulmonary metastasis of hepatocellular carcinoma associated with transarterial chemoembolization. J Hepatol 1995;23:563–568.

    Article  PubMed  CAS  Google Scholar 

  31. Bharat A, Brown DB, Crippin JS, Gould JE, Lowell JA, Shenoy S, et al. Pre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survival. J Am Coll Surg 2006;203:411–420.

    Article  PubMed  Google Scholar 

  32. Yao FY, Kinkhabwala M, LaBerge JM, Bass NM, Brown R Jr, Kerlan R, et al. The impact of pre-operative loco-regional therapy on outcome after liver transplantation for hepatocellular carcinoma. Am J Transpl 2005;5:795–804.

    Article  Google Scholar 

  33. Millonig G, Graziadei IW, Freund MC, Jaschke W, Stadlmann S, Ladurner R, et al. Response to preoperative chemoembolization correlates with outcome after liver transplantation in patients with hepatocellular carcinoma. Liver Transpl 2007;13:272–279.

    Article  PubMed  Google Scholar 

  34. Lu DS, Yu NC, Raman SS, Lassman C, Tong MJ, Britten C, et al. Percutaneous radiofrequency ablation of hepatocellular carcinoma as a bridge to liver transplantation. Hepatology 2005;41:1130–1137.

    Article  PubMed  Google Scholar 

  35. Mazzaferro V, Battiston C, Perrone S, Pulvirenti A, Regalia E, Romito R, et al. Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study. Ann Surg 2004;240:900–909.

    Article  PubMed  Google Scholar 

  36. Kawasaki S, Makuuchi M, Matsunami H, Hashikura Y, Ikegami T, Nakazawa Y, et al. Living related liver transplantation in adults. Ann Surg 1998;227:269–274.

    Article  PubMed  CAS  Google Scholar 

  37. Cheng SJ, Pratt DS, Freeman RB Jr, Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for nonresectable small hepatocellular carinoma and compensated cirrhosis: a decision analysis. Transplantation 2001;72:861–868.

    Article  PubMed  CAS  Google Scholar 

  38. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 2001;33:1073–1079.

    Article  PubMed  CAS  Google Scholar 

  39. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl 2004;10:440–447.

    Article  PubMed  Google Scholar 

  40. Furukawa H, Shimamura T, Suzuki T, Taniguchi M, Yamashita K, Kamiyama T, et al. Living-donor liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006;13:393–397.

    Article  PubMed  Google Scholar 

  41. Fisher RA, Kulik LM, Freise CE, Lok ASF, Shearon TH, Brown RS Jr, et al. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am J Transpl 2007;7:1601–1608.

    Article  CAS  Google Scholar 

  42. Hwang S, Lee SG, Ahn CS, Kim KH, Moon DB, Ha TY, et al. Small-size liver graft does not increase the risk of hepatocellular carcinoma recurrence after living donor liver transplantation. Transplant Proc 2007;39:1526–1529.

    Article  PubMed  CAS  Google Scholar 

  43. Efimova EA, Glanemann M, Liu L, Schumacher G, Settmacher U, Jonas SE, et al. Effects of human hepatocyte growth factor on the proliferation of human hepatocytes and hepatocellular carcinoma cell lines. Eur Surg Res 2004;36:300–307.

    Article  PubMed  CAS  Google Scholar 

  44. Florman S, Miller C. Live donor liver transplantation. Liver Transpl 2006;14:499–510.

    Article  Google Scholar 

  45. Bramstedt K. Living liver donor mortality: where do we stand? Am J Gastroenterol 2006;101:755–759.

    Article  PubMed  Google Scholar 

  46. Chan SC, Fan ST, Lo CM, Liu CL, Wong J. Towards current standards of donor right hepatectomy for adult-to-adult liver donor liver transplantation through the experience of 200 cases. Ann Surg 2007;245:110–117.

    Article  PubMed  Google Scholar 

  47. Kokudo N, Sugawara Y, Imamura H, Sano K, Makuuchi M. Tailoring type of donor hepatectomy for adult living donor liver transplantation. Am J Transpl 2005;5:1694–1703.

    Article  Google Scholar 

  48. Hwang S, Lee SG, Lee YJ, Sung KB, Park KM, Kim KH, et al. Lessons learned from 1000 living donor liver transplantations in a single center: how to make living donations safe. Liver Transpl 2006;12:920–927.

    Article  PubMed  Google Scholar 

  49. Zavaglia C, De Carlis L, Alberti AB, Minola E, Belli LS, Slim AO, et al. Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol 2005;100:2708–2716.

    Article  PubMed  Google Scholar 

  50. Grasso A, Stigliano R, Morisco F, Martines H, Quaglia A, Dhillon AP, et al. Liver transplantation and recurrent hepatocellular carcinoma: predictive value of nodule size in a retrospective and explant study. Transplantation 2006;81:1532–1541.

    Article  PubMed  Google Scholar 

  51. Merli M, Nicolini G, Gentili F, Novelli G, Iappelli M, Casciaro G, et al. Predictive factors of outcome after liver transplantation in patients with cirrhosis and hepatocellular carcinoma. Transplant Proc 2005;37:2535–2540.

    Article  PubMed  CAS  Google Scholar 

  52. Yao FY, Hirose R, LaBerge JM, Davern TJ 3rd, Bass NM, Kerlan RK Jr, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl 2005;11:1505–1514.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Surgery and Science, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan

    Akinobu Taketomi, Yuji Soejima, Tomoharu Yoshizumi, Hideaki Uchiyama, Yo-Ichi Yamashita & Yoshihiko Maehara

Authors
  1. Akinobu Taketomi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yuji Soejima
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Tomoharu Yoshizumi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hideaki Uchiyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yo-Ichi Yamashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yoshihiko Maehara
    View author publications

    You can also search for this author in PubMed Google Scholar

About this article

Cite this article

Taketomi, A., Soejima, Y., Yoshizumi, T. et al. Liver transplantation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 15, 124–130 (2008). https://doi.org/10.1007/s00534-007-1296-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00534-007-1296-4

Key words

Search

Navigation